Infinity Z Score

INFI -  USA Stock  

USD 0.58  0.01  1.75%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Please see Infinity Pharmaceuti Piotroski F Score and Infinity Pharmaceuti Valuation analysis.
  
Refresh
Infinity Pharmaceuti Working Capital is most likely to decrease significantly in the upcoming years. The last year's value of Working Capital was reported at 68.97 Million. Infinity Pharmaceuti Operating Expenses is most likely to decrease significantly in the upcoming years. The last year's value of Operating Expenses was reported at 46.94 Million. The current Revenues is estimated to increase to about 1.9 M, while Consolidated Income is projected to decrease to (48.8 M).

Infinity Z Score Analysis

Infinity Pharmaceuti's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
 2019 2020 2021 2022 (projected)
Interest Expense2.56 M2.44 M180 K184.74 K
Gross Profit3.05 M1.72 M1.86 M1.91 M
Z Score 
 = 
Sum Of  
 
5 Factors 
More About Z Score | All Equity Analysis

Current Infinity Pharmaceuti Z Score

    
  20.0  
Most of Infinity Pharmaceuti's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Infinity Pharmaceuti is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
First Factor
 = 
1.2 * (
Working Capital
/
Total Assets )
Second Factor
 = 
1.4 * (
Retained Earnings
/
Total Assets )
Thrid Factor
 = 
3.3 * (
EBITAD
/
Total Assets )
Fouth Factor
 = 
0.6 * (
Market Value of Equity
/
Total Liabilities )
Fifth Factor
 = 
0.99 * (
Revenue
/
Total Assets )

Infinity Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Infinity Pharmaceuti is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since Infinity Pharmaceuti's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Infinity Pharmaceuti's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Infinity Pharmaceuti's interrelated accounts and indicators.
To calculate Z-Score one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition

According to the company's disclosures, Infinity Pharmaceuti has a Z Score of 20.0. This is 196.3% higher than that of the Healthcare sector and notably higher than that of the Biotechnology industry. The z score for all United States stocks is 129.36% lower than that of the firm.

Infinity Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Infinity Pharmaceuti's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Infinity Pharmaceuti could also be used in its relative valuation, which is a method of valuing Infinity Pharmaceuti by comparing valuation metrics of similar companies.
Infinity Pharmaceuti is currently under evaluation in z score category among related companies.

Infinity Pharmaceuti Current Valuation Drivers

We derive many important indicators used in calculating different scores of Infinity Pharmaceuti from analyzing Infinity Pharmaceuti's financial statements. These drivers represent accounts that assess Infinity Pharmaceuti's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Infinity Pharmaceuti's important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee(1.9 M)(450.12 K)(1.88 M)(1.76 M)(2.02 M)(2.07 M)
Revenue Per Employee272.73 K885.84 K121.96 K74.53 K85.72 K87.97 K
Average Assets79.52 M56.84 M62.83 M48.01 M98.6 M115.5 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(39.83 M)(10.97 M)(44.33 M)(37.56 M)(44.6 M)(48.12 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(39.83 M)(10.97 M)(44.33 M)(37.56 M)(44.6 M)(48.12 M)
Earnings before Tax(42.55 M)(11.25 M)(47.11 M)(40.49 M)(45.26 M)(48.84 M)
Average Equity58.45 M50.8 M23.83 M(12.69 M)36.83 M55.8 M
Enterprise Value75.36 M34.89 M34.8 M119.15 M111.25 M114.18 M
Free Cash Flow(36 M)(4.71 M)(43.86 M)(35.78 M)(40.63 M)(43.84 M)
Invested Capital19.15 M3.88 M18.98 M1.11 M(8.32 M)(8.54 M)
Invested Capital Average29 M10.69 M20.72 M13.29 M(5.41 M)(5.55 M)
Market Capitalization102.94 M67.1 M54.75 M136.12 M200.28 M263.12 M
Tangible Asset Value59.35 M60.22 M49.01 M39.32 M84.78 M112.27 M
Working Capital46.79 M52.1 M34.88 M24.97 M68.97 M89.22 M

Infinity Pharmaceuti Institutional Holders

Institutional Holdings refers to the ownership stake in Infinity Pharmaceuti that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Infinity Pharmaceuti's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Infinity Pharmaceuti's value.
Security TypeSharesValue
Blackrock IncCommon Shares6.6 M7.5 M
Bvf IncCommon Shares6.4 M7.2 M
Vanguard Group IncCommon Shares5.8 M6.6 M
Polar Capital Holdings PlcCommon SharesM5.7 M
State Street CorpCommon Shares1.9 M2.1 M
Geode Capital Management LlcCommon Shares1.4 M1.6 M
D E Shaw Co IncCommon Shares1.1 M1.3 M

Infinity Fundamentals

About Infinity Pharmaceuti Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Infinity Pharmaceuti's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Infinity Pharmaceuti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Infinity Pharmaceuti based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Infinity Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Infinity Pharmaceuti without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Fund Screener Now

   

Fund Screener

Find actively-traded funds from around the world traded on over 30 global exchanges
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Infinity Pharmaceuti using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Infinity Pharmaceuti Piotroski F Score and Infinity Pharmaceuti Valuation analysis. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Infinity Stock analysis

When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Is Infinity Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Infinity Pharmaceuti. If investors know Infinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Infinity Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.